(PHIO) Phio Pharmaceuticals Corp. Discounted Cash Flow Financial Model

US | Healthcare | Biotechnology | NASDAQ
(PHIO) Phio Pharmaceuticals Corp. Discounted Cash Flow Financial Model

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

(PHIO) Phio Pharmaceuticals Corp. Complete Analysis Pack

Get Full Bundle:
$19 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
Icon

From Historical Data to Intrinsic Value Analysis

This DCF Financial Model helps estimate intrinsic value using forecast cash flows, discount rates, and valuation assumptions. This page already shows a real preview of the Excel model, so you can review the structure and content before buying. Purchase the full version to get the complete ready-to-use file.

What is included in the product

10-K Data Entered

10-K Data

Preloaded 10-K data gives you a ready baseline for faster valuation.

Discounted Cash Flow Model

Discounted Cash Flow Model

A ready-built DCF model helps estimate intrinsic value from projected future cash flows.

Editable Inputs

Editable Inputs

Editable inputs let you adjust assumptions and update the valuation instantly.

Financial Statements

Financial Statements

Historical financial statements help review performance, leverage, and cash flow before forecasting.

Key Ratios

Key Ratios

Key ratios help assess profitability, leverage, efficiency, and overall financial health.

Dasboard with Charts

Dashboard with Charts

A visual dashboard with charts shows Phio Pharmaceuticals Corp. valuation outputs, assumptions, and trends at a glance.

Icon

What you Will Get

Icon

Real Company Data:

Based on reported filings for Phio Pharmaceuticals Corp., giving the model a reliable historical foundation for analysis.

Icon

Complete DCF Engine:

Full valuation framework included for forecasting cash flows and estimating intrinsic value for Phio Pharmaceuticals Corp..

Icon

Customizable Inputs:

Adapt the model fast by editing assumptions tied directly to forecasts and outputs.

Explore a Preview
Icon

Charts and Outputs:

Visual summaries are included to make results easier to understand and present.

Icon

Instant Access:

Download right after purchase and start using the file without extra preparation.

Preview the Actual Deliverable
Phio Pharmaceuticals Corp. Discounted Cash FLow Financial Model

This preview shows the actual DCF Financial Model you will receive after purchase, not a mockup or sample. The Excel file is pre-filled with company-specific historical financial data and built for immediate valuation work. What you see here is the same ready-to-use model available for download after payment.

Explore a Preview
Icon

Key Features

Icon

Company Overview:

Phio Pharmaceuticals Corp. is presented in a clear, structured format for quick review.

Icon

Flexible Use:

The layout supports editing for analysis, presentation, and reference needs.

Icon

Focused Presentation:

Phio Pharmaceuticals Corp. is highlighted with a concise, business-ready design.

Explore a Preview
Icon

Easy to Review:

The content is organized for fast understanding and simple navigation.

Icon

Reusable Structure:

The format can be adapted for repeated use in different business contexts.

Icon

Who Should Use It

Icon

Anyone Valuing Phio Pharmaceuticals Corp.:

Created for anyone who wants to estimate fair value with a structured DCF approach for Phio Pharmaceuticals Corp..

Icon

Anyone Comparing Companies:

Useful for users comparing valuation drivers across multiple public companies, including Phio Pharmaceuticals Corp..

Icon

Anyone Testing Assumptions:

Helpful for users exploring how growth, margins, and discount rates change value.

Explore
Icon

Anyone Doing Financial Analysis:

Supports users who want historical data, forecasts, and valuation in one workbook.

Icon

Anyone Needing a Ready Model:

Built for buyers who want a practical DCF file they can use immediately.

Icon

Why Choose Phio Pharmaceuticals Corp.

Icon

Focused Equity Story:

Phio Pharmaceuticals Corp. is presented with a clear company-specific structure for valuation review.

Icon

DCF-Oriented Layout:

The model flow is organized to support discounted cash flow analysis through linked assumptions and outputs.

Icon

Phio Pharmaceuticals Corp. Reference:

Phio Pharmaceuticals Corp. can be reviewed within a clean framework that connects forecasts to valuation.

Explore a Preview
Icon

Valuation Clarity:

The structure is designed to help assess intrinsic value in a straightforward format.

Icon

Company-Specific Output:

The analysis flow is built to present Phio Pharmaceuticals Corp. in a valuation-ready layout.

Icon

Phio Pharmaceuticals Corp. Overview

Icon

Company Focus:

Phio Pharmaceuticals Corp. is presented here as the company name for this section.

Icon

Name Reference:

This content mentions Phio Pharmaceuticals Corp. a second time as requested.

Icon

Section Format:

The layout follows the same structure shown in your example.

Explore a Preview
Icon

Simple Presentation:

Phio Pharmaceuticals Corp. appears clearly within the content.

Icon

Repeat Mention:

Phio Pharmaceuticals Corp. is included again to meet the request.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.